nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—BAAT—liver—bile duct cancer	0.0534	0.0777	CbGeAlD
Glycine—ALAS2—pancreas—bile duct cancer	0.0385	0.0561	CbGeAlD
Glycine—GLYATL1—liver—bile duct cancer	0.0344	0.0501	CbGeAlD
Glycine—GLYAT—liver—bile duct cancer	0.0323	0.0471	CbGeAlD
Glycine—GNMT—pancreas—bile duct cancer	0.0292	0.0425	CbGeAlD
Glycine—PIPOX—pancreas—bile duct cancer	0.0258	0.0376	CbGeAlD
Glycine—ALAS2—liver—bile duct cancer	0.0245	0.0357	CbGeAlD
Glycine—AGXT—liver—bile duct cancer	0.0222	0.0323	CbGeAlD
Glycine—ALAS1—pancreas—bile duct cancer	0.022	0.032	CbGeAlD
Glycine—GSS—Glutathione metabolism—IDH1—bile duct cancer	0.0218	0.0698	CbGpPWpGaD
Glycine—GCSH—liver—bile duct cancer	0.0213	0.0309	CbGeAlD
Glycine—GARS—pancreas—bile duct cancer	0.02	0.0291	CbGeAlD
Glycine—SLC6A9—lymph node—bile duct cancer	0.02	0.0291	CbGeAlD
Glycine—GATM—pancreas—bile duct cancer	0.019	0.0276	CbGeAlD
Glycine—AGXT2—liver—bile duct cancer	0.0189	0.0274	CbGeAlD
Glycine—GNMT—liver—bile duct cancer	0.0186	0.027	CbGeAlD
Glycine—GLDC—liver—bile duct cancer	0.0176	0.0256	CbGeAlD
Glycine—GPR18—lymph node—bile duct cancer	0.0174	0.0253	CbGeAlD
Glycine—PIPOX—liver—bile duct cancer	0.0164	0.0239	CbGeAlD
Glycine—GCSH—lymph node—bile duct cancer	0.0163	0.0237	CbGeAlD
Glycine—GCAT—liver—bile duct cancer	0.0159	0.0232	CbGeAlD
Glycine—ALAS1—liver—bile duct cancer	0.014	0.0203	CbGeAlD
Glycine—SLC36A1—pancreas—bile duct cancer	0.0135	0.0197	CbGeAlD
Glycine—GLDC—lymph node—bile duct cancer	0.0135	0.0197	CbGeAlD
Glycine—SLC32A1—Amino acid and oligopeptide SLC transporters—SLC5A5—bile duct cancer	0.0131	0.0418	CbGpPWpGaD
Glycine—GARS—liver—bile duct cancer	0.0127	0.0185	CbGeAlD
Glycine—GCAT—lymph node—bile duct cancer	0.0122	0.0178	CbGeAlD
Glycine—GATM—liver—bile duct cancer	0.0121	0.0176	CbGeAlD
Glycine—GSS—pancreas—bile duct cancer	0.0119	0.0173	CbGeAlD
Glycine—SHMT2—liver—bile duct cancer	0.0111	0.0161	CbGeAlD
Glycine—ALAS1—lymph node—bile duct cancer	0.0107	0.0156	CbGeAlD
Glycine—SHMT1—liver—bile duct cancer	0.0101	0.0147	CbGeAlD
Glycine—GARS—lymph node—bile duct cancer	0.00976	0.0142	CbGeAlD
Glycine—GATM—lymph node—bile duct cancer	0.00927	0.0135	CbGeAlD
Glycine—SLC36A1—liver—bile duct cancer	0.0086	0.0125	CbGeAlD
Glycine—SHMT2—lymph node—bile duct cancer	0.00849	0.0124	CbGeAlD
Glycine—GLRB—lymph node—bile duct cancer	0.00796	0.0116	CbGeAlD
Glycine—SHMT1—lymph node—bile duct cancer	0.00773	0.0113	CbGeAlD
Glycine—SLC32A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—bile duct cancer	0.0077	0.0246	CbGpPWpGaD
Glycine—GSS—liver—bile duct cancer	0.00757	0.011	CbGeAlD
Glycine—SLC36A1—Amino acid and oligopeptide SLC transporters—SLC5A5—bile duct cancer	0.00751	0.024	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00663	0.0212	CbGpPWpGaD
Glycine—SLC36A1—lymph node—bile duct cancer	0.00659	0.0096	CbGeAlD
Glycine—SLC6A9—NRF2 pathway—SLC5A5—bile duct cancer	0.00642	0.0205	CbGpPWpGaD
Glycine—SLC6A5—NRF2 pathway—SLC5A5—bile duct cancer	0.00642	0.0205	CbGpPWpGaD
Glycine—GSS—lymph node—bile duct cancer	0.00581	0.00845	CbGeAlD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00573	0.0183	CbGpPWpGaD
Glycine—SLC16A10—liver—bile duct cancer	0.00555	0.00807	CbGeAlD
Glycine—SLC6A5—NRF2 pathway—TGFBR2—bile duct cancer	0.00517	0.0165	CbGpPWpGaD
Glycine—SLC6A9—NRF2 pathway—TGFBR2—bile duct cancer	0.00517	0.0165	CbGpPWpGaD
Glycine—SLC6A9—NRF2 pathway—HGF—bile duct cancer	0.00475	0.0152	CbGpPWpGaD
Glycine—SLC6A5—NRF2 pathway—HGF—bile duct cancer	0.00475	0.0152	CbGpPWpGaD
Glycine—GATM—Amino acid and derivative metabolism—SLC5A5—bile duct cancer	0.00467	0.0149	CbGpPWpGaD
Glycine—SLC16A10—Amino acid and oligopeptide SLC transporters—SLC5A5—bile duct cancer	0.00456	0.0146	CbGpPWpGaD
Glycine—SLC36A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—bile duct cancer	0.00442	0.0141	CbGpPWpGaD
Glycine—SLC16A10—lymph node—bile duct cancer	0.00425	0.00619	CbGeAlD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—SMAD4—bile duct cancer	0.0042	0.0134	CbGpPWpGaD
Glycine—ALAS2—Metabolism—FAR2—bile duct cancer	0.00409	0.0131	CbGpPWpGaD
Glycine—SLC6A9—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.00404	0.0129	CbGpPWpGaD
Glycine—SLC6A5—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.00404	0.0129	CbGpPWpGaD
Glycine—AGXT—Amino acid and derivative metabolism—SLC5A5—bile duct cancer	0.00397	0.0127	CbGpPWpGaD
Glycine—SLC32A1—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.00344	0.011	CbGpPWpGaD
Glycine—AGXT2—Amino acid and derivative metabolism—SLC5A5—bile duct cancer	0.00338	0.0108	CbGpPWpGaD
Glycine—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—bile duct cancer	0.00321	0.0103	CbGpPWpGaD
Glycine—GATM—Metabolism—FAR2—bile duct cancer	0.0031	0.0099	CbGpPWpGaD
Glycine—GLYAT—Metabolism—FAR2—bile duct cancer	0.0031	0.0099	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—FAR2—bile duct cancer	0.0031	0.0099	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—FAR2—bile duct cancer	0.0031	0.0099	CbGpPWpGaD
Glycine—GPR18—G alpha (i) signalling events—GNAS—bile duct cancer	0.00304	0.00971	CbGpPWpGaD
Glycine—SHMT2—Vitamin B12 Metabolism—IL6—bile duct cancer	0.00302	0.00964	CbGpPWpGaD
Glycine—BAAT—Metabolism—FAR2—bile duct cancer	0.00295	0.00944	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00279	0.00891	CbGpPWpGaD
Glycine—GARS—Gene Expression—MBD2—bile duct cancer	0.00276	0.00882	CbGpPWpGaD
Glycine—SHMT1—Amino acid and derivative metabolism—SLC5A5—bile duct cancer	0.00275	0.0088	CbGpPWpGaD
Glycine—SLC16A10—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—bile duct cancer	0.00269	0.00859	CbGpPWpGaD
Glycine—SHMT2—Folate Metabolism—TP53—bile duct cancer	0.00268	0.00857	CbGpPWpGaD
Glycine—AGXT—Metabolism—FAR2—bile duct cancer	0.00263	0.00842	CbGpPWpGaD
Glycine—ALAS1—Metabolism—FAR2—bile duct cancer	0.00255	0.00815	CbGpPWpGaD
Glycine—SHMT2—Folate Metabolism—IL6—bile duct cancer	0.00245	0.00785	CbGpPWpGaD
Glycine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—bile duct cancer	0.00245	0.00784	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.0024	0.00769	CbGpPWpGaD
Glycine—GRIN2C—CREB phosphorylation through the activation of Ras—HRAS—bile duct cancer	0.00229	0.00732	CbGpPWpGaD
Glycine—AGXT2—Metabolism—FAR2—bile duct cancer	0.00224	0.00716	CbGpPWpGaD
Glycine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bile duct cancer	0.00213	0.0068	CbGpPWpGaD
Glycine—SLC6A5—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00206	0.00657	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00206	0.00657	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—MMP9—bile duct cancer	0.00202	0.00645	CbGpPWpGaD
Glycine—ALAS2—Metabolism—IDH2—bile duct cancer	0.002	0.00638	CbGpPWpGaD
Glycine—SLC36A1—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.00198	0.00631	CbGpPWpGaD
Glycine—SLC6A5—NRF2 pathway—TGFB1—bile duct cancer	0.00194	0.00619	CbGpPWpGaD
Glycine—SLC6A9—NRF2 pathway—TGFB1—bile duct cancer	0.00194	0.00619	CbGpPWpGaD
Glycine—GRIN2C—Post NMDA receptor activation events—HRAS—bile duct cancer	0.00188	0.00602	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—GNAS—bile duct cancer	0.00184	0.00588	CbGpPWpGaD
Glycine—SHMT1—Metabolism—FAR2—bile duct cancer	0.00183	0.00583	CbGpPWpGaD
Glycine—GSS—Metabolism—FAR2—bile duct cancer	0.00178	0.00569	CbGpPWpGaD
Glycine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—bile duct cancer	0.00175	0.00559	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00175	0.00559	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00175	0.00559	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00175	0.00559	CbGpPWpGaD
Glycine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—bile duct cancer	0.00174	0.00555	CbGpPWpGaD
Glycine—ALAS2—Metabolism—IDH1—bile duct cancer	0.00172	0.00549	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.0016	0.00511	CbGpPWpGaD
Glycine—SLC6A5—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.0016	0.00511	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—TP53—bile duct cancer	0.00158	0.00505	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—IDH2—bile duct cancer	0.00151	0.00483	CbGpPWpGaD
Glycine—GATM—Metabolism—IDH2—bile duct cancer	0.00151	0.00483	CbGpPWpGaD
Glycine—GLYAT—Metabolism—IDH2—bile duct cancer	0.00151	0.00483	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—IDH2—bile duct cancer	0.00151	0.00483	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—IL6—bile duct cancer	0.00145	0.00462	CbGpPWpGaD
Glycine—BAAT—Metabolism—IDH2—bile duct cancer	0.00144	0.00461	CbGpPWpGaD
Glycine—GRIN2A—Post NMDA receptor activation events—HRAS—bile duct cancer	0.00144	0.0046	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00142	0.00455	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—bile duct cancer	0.00137	0.00438	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00136	0.00434	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00136	0.00434	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00136	0.00434	CbGpPWpGaD
Glycine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—bile duct cancer	0.00133	0.00424	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—IDH1—bile duct cancer	0.0013	0.00416	CbGpPWpGaD
Glycine—GATM—Metabolism—IDH1—bile duct cancer	0.0013	0.00416	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—IDH1—bile duct cancer	0.0013	0.00416	CbGpPWpGaD
Glycine—GLYAT—Metabolism—IDH1—bile duct cancer	0.0013	0.00416	CbGpPWpGaD
Glycine—AGXT—Metabolism—IDH2—bile duct cancer	0.00129	0.00411	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RNF43—bile duct cancer	0.00126	0.00404	CbGpPWpGaD
Glycine—ALAS1—Metabolism—IDH2—bile duct cancer	0.00125	0.00398	CbGpPWpGaD
Glycine—BAAT—Metabolism—IDH1—bile duct cancer	0.00124	0.00397	CbGpPWpGaD
Glycine—SLC16A10—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.0012	0.00384	CbGpPWpGaD
Glycine—ALAS2—Metabolism—SLC5A5—bile duct cancer	0.00113	0.00362	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00113	0.0036	CbGpPWpGaD
Glycine—GARS—Gene Expression—SMAD4—bile duct cancer	0.00111	0.00355	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00111	0.00354	CbGpPWpGaD
Glycine—AGXT—Metabolism—IDH1—bile duct cancer	0.00111	0.00353	CbGpPWpGaD
Glycine—AGXT2—Metabolism—IDH2—bile duct cancer	0.00109	0.0035	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—TP53—bile duct cancer	0.00107	0.00343	CbGpPWpGaD
Glycine—ALAS1—Metabolism—IDH1—bile duct cancer	0.00107	0.00342	CbGpPWpGaD
Glycine—SHMT1—Disease—RNF43—bile duct cancer	0.00106	0.0034	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—GNAS—bile duct cancer	0.00104	0.00332	CbGpPWpGaD
Glycine—SLC32A1—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.00101	0.00322	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.001	0.00321	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—GNAS—bile duct cancer	0.000944	0.00302	CbGpPWpGaD
Glycine—AGXT2—Metabolism—IDH1—bile duct cancer	0.00094	0.00301	CbGpPWpGaD
Glycine—SHMT1—Disease—IDH1—bile duct cancer	0.000915	0.00293	CbGpPWpGaD
Glycine—SHMT1—Metabolism—IDH2—bile duct cancer	0.000891	0.00285	CbGpPWpGaD
Glycine—ALAS2—Metabolism—GNAS—bile duct cancer	0.00088	0.00281	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000875	0.0028	CbGpPWpGaD
Glycine—GSS—Metabolism—IDH2—bile duct cancer	0.000869	0.00278	CbGpPWpGaD
Glycine—GLYAT—Metabolism—SLC5A5—bile duct cancer	0.000858	0.00274	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—SLC5A5—bile duct cancer	0.000858	0.00274	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—SLC5A5—bile duct cancer	0.000858	0.00274	CbGpPWpGaD
Glycine—GATM—Metabolism—SLC5A5—bile duct cancer	0.000858	0.00274	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—TP53—bile duct cancer	0.00082	0.00262	CbGpPWpGaD
Glycine—BAAT—Metabolism—SLC5A5—bile duct cancer	0.000819	0.00262	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00078	0.00249	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—HRAS—bile duct cancer	0.000772	0.00247	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000767	0.00245	CbGpPWpGaD
Glycine—SHMT1—Metabolism—IDH1—bile duct cancer	0.000767	0.00245	CbGpPWpGaD
Glycine—GSS—Metabolism—IDH1—bile duct cancer	0.000747	0.00239	CbGpPWpGaD
Glycine—AGXT—Metabolism—SLC5A5—bile duct cancer	0.00073	0.00233	CbGpPWpGaD
Glycine—ALAS1—Metabolism—SLC5A5—bile duct cancer	0.000707	0.00226	CbGpPWpGaD
Glycine—GATM—Metabolism—GNAS—bile duct cancer	0.000667	0.00213	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—GNAS—bile duct cancer	0.000667	0.00213	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—GNAS—bile duct cancer	0.000667	0.00213	CbGpPWpGaD
Glycine—GLYAT—Metabolism—GNAS—bile duct cancer	0.000667	0.00213	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000662	0.00212	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—bile duct cancer	0.00065	0.00208	CbGpPWpGaD
Glycine—BAAT—Metabolism—GNAS—bile duct cancer	0.000636	0.00203	CbGpPWpGaD
Glycine—AGXT2—Metabolism—SLC5A5—bile duct cancer	0.00062	0.00198	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00061	0.00195	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TGFBR2—bile duct cancer	0.000578	0.00185	CbGpPWpGaD
Glycine—AGXT—Metabolism—GNAS—bile duct cancer	0.000567	0.00181	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—GNAS—bile duct cancer	0.000558	0.00178	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GNAS—bile duct cancer	0.000549	0.00176	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SMAD4—bile duct cancer	0.000547	0.00175	CbGpPWpGaD
Glycine—SHMT1—Metabolism—SLC5A5—bile duct cancer	0.000506	0.00162	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—bile duct cancer	0.000496	0.00159	CbGpPWpGaD
Glycine—GSS—Metabolism—SLC5A5—bile duct cancer	0.000493	0.00158	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.000489	0.00156	CbGpPWpGaD
Glycine—SHMT1—Disease—TGFBR2—bile duct cancer	0.000486	0.00155	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GNAS—bile duct cancer	0.000482	0.00154	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000474	0.00152	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTGS2—bile duct cancer	0.000472	0.00151	CbGpPWpGaD
Glycine—SHMT1—Disease—SMAD4—bile duct cancer	0.00046	0.00147	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—NRAS—bile duct cancer	0.000394	0.00126	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GNAS—bile duct cancer	0.000393	0.00126	CbGpPWpGaD
Glycine—GSS—Metabolism—GNAS—bile duct cancer	0.000383	0.00122	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—HRAS—bile duct cancer	0.000374	0.0012	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.000373	0.00119	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—EGFR—bile duct cancer	0.000359	0.00115	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTGS2—bile duct cancer	0.000358	0.00114	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTGS2—bile duct cancer	0.000358	0.00114	CbGpPWpGaD
Glycine—GATM—Metabolism—PTGS2—bile duct cancer	0.000358	0.00114	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTGS2—bile duct cancer	0.000358	0.00114	CbGpPWpGaD
Glycine—SHMT1—Disease—NOS2—bile duct cancer	0.000343	0.0011	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTGS2—bile duct cancer	0.000342	0.00109	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—KRAS—bile duct cancer	0.000339	0.00108	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ERBB2—bile duct cancer	0.000306	0.000979	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTGS2—bile duct cancer	0.000304	0.000973	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTGS2—bile duct cancer	0.000295	0.000943	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HRAS—bile duct cancer	0.000289	0.000922	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—HRAS—bile duct cancer	0.000286	0.000913	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6—bile duct cancer	0.000276	0.000883	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MMP9—bile duct cancer	0.000263	0.00084	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTGS2—bile duct cancer	0.000259	0.000828	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB2—bile duct cancer	0.000258	0.000824	CbGpPWpGaD
Glycine—SHMT1—Disease—PTGS2—bile duct cancer	0.000252	0.000806	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NRAS—bile duct cancer	0.000233	0.000745	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TGFB1—bile duct cancer	0.000216	0.000692	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGFR—bile duct cancer	0.000212	0.000678	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTGS2—bile duct cancer	0.000211	0.000675	CbGpPWpGaD
Glycine—GSS—Metabolism—PTGS2—bile duct cancer	0.000206	0.000657	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KRAS—bile duct cancer	0.000201	0.000641	CbGpPWpGaD
Glycine—SHMT1—Disease—NRAS—bile duct cancer	0.000196	0.000627	CbGpPWpGaD
Glycine—SHMT1—Disease—TGFB1—bile duct cancer	0.000182	0.000582	CbGpPWpGaD
Glycine—SHMT1—Disease—EGFR—bile duct cancer	0.000179	0.000571	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—bile duct cancer	0.000178	0.00057	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HRAS—bile duct cancer	0.00017	0.000545	CbGpPWpGaD
Glycine—SHMT1—Disease—KRAS—bile duct cancer	0.000169	0.000539	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6—bile duct cancer	0.000163	0.000521	CbGpPWpGaD
Glycine—SHMT1—Disease—HRAS—bile duct cancer	0.000143	0.000459	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6—bile duct cancer	0.000137	0.000439	CbGpPWpGaD
